Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis

Rosita Saraceno; Steven P. Nisticò; Elisabetta Capriotti; Catia De Felice; Lesley E. Rhodes; Sergio Chimenti

doi:10.1111/j.1600-0781.2008.00318.x

Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis

Rosita Saraceno
, Steven P. Nisticò
, Elisabetta Capriotti
, Catia De Felice
, Lesley E. Rhodes
, Sergio Chimenti

Research output: Contribution to journal › Article › peer-review

Abstract

Three hundred and eight nanometre excimer light has been reported to be safe and effective in the treatment of chronic skin diseases, but the range of potential applications has not been fully explored. Our objective was to assess the efficacy of monochromatic excimer light (MEL) in the treatment of prurigo nodularis (PN). Eleven patients were enrolled in this pilot study. Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%). © 2008 Blackwell Munksgaard.

Original language	English
Pages (from-to)	43-45
Number of pages	2
Journal	Photodermatology Photoimmunology and Photomedicine
Volume	24
Issue number	1
DOIs	https://doi.org/10.1111/j.1600-0781.2008.00318.x
Publication status	Published - Feb 2008

Keywords

308 nm
MEL
Prurigo nodularis

Access to Document

10.1111/j.1600-0781.2008.00318.x

Cite this

@article{7f897cbce6064e6fa2e53492e2df4b30,

title = "Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis",

abstract = "Three hundred and eight nanometre excimer light has been reported to be safe and effective in the treatment of chronic skin diseases, but the range of potential applications has not been fully explored. Our objective was to assess the efficacy of monochromatic excimer light (MEL) in the treatment of prurigo nodularis (PN). Eleven patients were enrolled in this pilot study. Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81\%). {\textcopyright} 2008 Blackwell Munksgaard.",

keywords = "308 nm, MEL, Prurigo nodularis",

author = "Rosita Saraceno and Nistic{\`o}, \{Steven P.\} and Elisabetta Capriotti and \{De Felice\}, Catia and Rhodes, \{Lesley E.\} and Sergio Chimenti",

year = "2008",

month = feb,

doi = "10.1111/j.1600-0781.2008.00318.x",

language = "English",

volume = "24",

pages = "43--45",

journal = "Photodermatology Photoimmunology and Photomedicine",

issn = "1600-0781",

publisher = "Blackwell Munksgaard",

number = "1",

}

TY - JOUR

T1 - Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis

AU - Saraceno, Rosita

AU - Nisticò, Steven P.

AU - Capriotti, Elisabetta

AU - De Felice, Catia

AU - Rhodes, Lesley E.

AU - Chimenti, Sergio

PY - 2008/2

Y1 - 2008/2

N2 - Three hundred and eight nanometre excimer light has been reported to be safe and effective in the treatment of chronic skin diseases, but the range of potential applications has not been fully explored. Our objective was to assess the efficacy of monochromatic excimer light (MEL) in the treatment of prurigo nodularis (PN). Eleven patients were enrolled in this pilot study. Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%). © 2008 Blackwell Munksgaard.

AB - Three hundred and eight nanometre excimer light has been reported to be safe and effective in the treatment of chronic skin diseases, but the range of potential applications has not been fully explored. Our objective was to assess the efficacy of monochromatic excimer light (MEL) in the treatment of prurigo nodularis (PN). Eleven patients were enrolled in this pilot study. Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%). © 2008 Blackwell Munksgaard.

KW - 308 nm

KW - MEL

KW - Prurigo nodularis

U2 - 10.1111/j.1600-0781.2008.00318.x

DO - 10.1111/j.1600-0781.2008.00318.x

M3 - Article

SN - 1600-0781

VL - 24

SP - 43

EP - 45

JO - Photodermatology Photoimmunology and Photomedicine

JF - Photodermatology Photoimmunology and Photomedicine

IS - 1

ER -

Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis

Abstract

Keywords

Access to Document

Fingerprint

Cite this